NSE filing, NSE: SHADOWFAX. Summary written from the filing by ALFA Finder's alert engine.
Shadowfax Technologies Ltd: key numbers
- Share price
- ₹290.40
- Market cap
- ₹17,046 Cr
- Revenue (annual)
- ₹4,202 Cr
- Net profit (annual)
- ₹111.7 Cr
- P/E (TTM)
- 100.8×Sector 29.6×
- Promoter holding
- 16.46%-0.05% QoQ
- FII holding
- 16.34%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Shadowfax Technologies Ltd
All →Shadowfax Technologies Board Meeting Date
Shadowfax Technologies will hold a board meeting on 29 October 2026 to approve September 2026 quarter results. An earnings call follows the same day at 5 p.m.
Shadowfax Technologies Merger & Restructuring Worth ₹0.1 Cr
Shadowfax Technologies Limited is incorporating a wholly-owned subsidiary with a cash investment of ₹0.1 Crore.
- Value
- ₹0.10 Cr
Shadowfax Technologies Employee Stock Options
Shadowfax Technologies Limited announced the exercise of 49,098 stock options, realizing Rs. 4.91 Lakhs from the employee stock option scheme.
- Value
- ₹0.05 Cr
Shadowfax Technologies Employee Stock Options
Shadowfax Technologies Limited allotted equity shares under its Employee Stock Option Plan. This ESOP allotment resulted in a minor increase in the company's paid-up share capital.
Shadowfax Technologies Merger & Restructuring
Shadowfax Technologies approved the incorporation of a new wholly owned subsidiary in India. Additionally, the company allotted 49,098 equity shares following the exercise of ESOPs.
Shadowfax Technologies Other Announcement
Shadowfax Technologies updated its Corporate Identification Number (CIN) from U72300KA2015PLC150324 to L72300KA2015PLC150324, following its recent listing on NSE and BSE exchanges.
Other employee stock options announcements
All →RateGain Travel Technologies Employee Stock Options
RateGain granted 53,021 Stock Appreciation Rights under its SAR Scheme 2022 at ₹800 and ₹862.25 per unit. The grants vest over four years and are exercisable within three years of vesting.
- Execution
- Vesting over 4 years (10% Y1, 20% Y2, 30% Y3, 40% Y4); exercisable within 3 years of vesting
Aye Finance Employee Stock Options
Aye Finance's employee welfare trust transferred 89,501 equity shares to grantees on exercising ESOP options. The share capital remains unchanged, so no new issuance occurs.
Aarti Pharmalabs Employee Stock Options
Aarti Pharmalabs granted 850 stock options to employees under its PSOP 2023 at Rs.5 exercise price. This is an employee incentive grant, not a capital raise.
OnEMI Technology Solutions Employee Stock Options
OnEMI Technology allotted 69,000 equity shares on exercise of employee stock options under the Kissht ESOP 2022 plan. The shares rank pari passu with existing equity.
Bliss GVS Pharma Employee Stock Options
Bliss GVS Pharma seeks shareholder approval via postal ballot for new employee stock option plans 2026. Up to 26,50,000 options are proposed; voting closes November 27, 2026.
Bandhan Bank Employee Stock Options
Bandhan Bank's board granted 32,98,871 stock options under ESOP Series 1 (Tranche 9) at Rs 151.91 per option. The options vest over four years, with each option convertible into one equity share.